Skip to main content
KLRA logo

Kailera Therapeutics, Inc.

KLRANASDAQHealthcareBiotechnology

$12.77Today:- (-)

As of Oct 26, 2026 close

Market cap
$1.31B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$9.76$28.23
Volume (live)
-
Avg. volume (3M)
1.41M

Kailera Therapeutics, Inc. (KLRA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Kailera Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$45.00
+252.39% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest KLRA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Andy Hsieh
William Blair
BuyMaintains
-
Yaron Werber
TD Cowen
BuyMaintains
$57.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Roger Song
Jefferies
BuyMaintains
$48.00
Hardik Parikh
JP Morgan
BuyMaintains
$30.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for KLRA?

The analyst consensus rating for KLRA is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for KLRA?

The average 12-month price target for KLRA is $45.00, representing an upside of 252.4% from the Oct 26, 2026 close of $12.77.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.